Skip to main content

Advertisement

SpringerLink
Log in

Managing Older Patients with Coexistent Asthma and Chronic Obstructive Pulmonary Disease

Diagnostic and Therapeutic Challenges

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are common obstructive airway diseases, especially among older people. These conditions are associated with a significant and increasing disease burden. The diagnosis and management of asthma and COPD in older populations are complex, and consequently clinicians are faced with many therapeutic and diagnostic challenges. Both aging and obstructive airway diseases are associated with complex co-morbidities and these coexisting illnesses confound management. Moreover, the age-related physiological changes that occur in the lungs may lead to airflow limitation, and this may be difficult to distinguish from an active disease state. In practice, management of asthma and COPD is informed by disease-specific clinical practice guidelines; however, most older people with these conditions are excluded from clinical trials that are designed to inform practice, creating major evidence gaps. Furthermore, seldom do clinical practice guidelines consider the complexities of management in older populations. The problems experienced by older people are complex and multifactorial and our approach to management must reflect these challenges. Opportunities exist to improve the management and outcomes for older people with obstructive airway disease and there is an urgent need for clinical trials to test management approaches in this population; current research must consider the challenges and evidence gaps that exist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gibson PG, McDonald VM, Marks GB. Asthma in the older adult. Lancet. 2010;374(9743):803–13.

    Article  Google Scholar 

  2. McDonald VM, Simpson JL, Higgins I, et al. Multidimensional assessment of older people with asthma & COPD: clinical management and health status. Age Ageing. 2011;40(1):42–9.

    Article  PubMed  Google Scholar 

  3. Cosio BG, Agusti A. Comorbidity: a distinctive feature of elderly respiratory patients. Eur Respir Mon. 2009;43:205–16.

    Article  Google Scholar 

  4. Hanania NA, King MJ, Braman SS, et al. Asthma in the elderly: current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol. 2011;128(3 Suppl):S4–24.

    Article  PubMed  Google Scholar 

  5. McDonald VM, Gibson PG. Asthma mortality and management in older Australians: time for a new approach? Australas J Ageing. 2008;27:215.

    Article  PubMed  Google Scholar 

  6. Australian Centre for Asthma Monitoring. Asthma in Australia 2008. Canberra: Australian Institute of Health and Welfare; 2008. Contract No.: Report No. ACM 14.

  7. Navaratnam P, Jayawant SS, Pedersen CA, et al. Asthma pharmacotherapy prescribing in the ambulatory population of the United States: evidence of nonadherence to national guidelines and implications for elderly people. J Am Geriatr Soc. 2008;56(7):1312–7.

    Article  PubMed  Google Scholar 

  8. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ. 2010;182(7):673–8.

    Article  PubMed  Google Scholar 

  9. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402–7.

    Article  PubMed  CAS  Google Scholar 

  10. Buist SA, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet. 2007;370:741–50.

    Article  PubMed  Google Scholar 

  11. Antonelli Incalzi R, Pedone C, Pahor M. Multidimensional assessment and treatment of the elderly with COPD. Eur Respir Mon. 2009(43):35–55.

  12. Beasley R, Weatherall M, Travers J, et al. Time to define the disorders of the syndrome of COPD. Lancet. 2009;29:670–2.

    Article  Google Scholar 

  13. Guerra S. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol. 2009;9:409–16.

    Article  PubMed  Google Scholar 

  14. Fabbri LM, Luppi F, Beghé B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31:204–12.

    Article  PubMed  CAS  Google Scholar 

  15. Marks GB, Poulos LM, Jenkins CR, et al. Asthma in older adults: a holistic, person centred and problem oriented approach. Med J Aust. 2009;191(4):197–9.

    PubMed  Google Scholar 

  16. United Nations. Report of the Second World Assembly on Ageing. Madrid, Spain: United Nations; 2002.

  17. Productivity Commission. Economic implications of an ageing Australia, research report. Canberra: Commonwealth of Australia; 2005.

    Google Scholar 

  18. Asher MI, Montefort S, Björkstén B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross sectional surveys. Lancet. 2006;368(9537):733–43.

    Article  PubMed  Google Scholar 

  19. Bellia V, Scichilone N, Battaglia S. Asthma in the elderly. Eur Respir Mon. 2009;43:56–76.

    Article  Google Scholar 

  20. Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253–60.

    Article  PubMed  CAS  Google Scholar 

  21. Berend N. Normal ageing of the lung: implications for diagnosis and monitoring of asthma in older people. Med J Aust. 2005;183(1 Suppl):S28–9.

    PubMed  Google Scholar 

  22. De Martinis M, Franceschi C, Monti D, et al. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005;579(10):2035–9.

    Article  PubMed  CAS  Google Scholar 

  23. Meyer KC, Rosenthal NS, Sorergel P, et al. Neutrophils and low grade inflammation in the seemingly normal aging human lung. Mech Aging Dev. 1998;104(2):169–81.

    Article  PubMed  CAS  Google Scholar 

  24. Thompson AB, Scholer SG, Daughton DM, et al. Altered epithelial lining fluid parameters in old normal individuals. J Gerontol. 1992;47(5):M171–6.

    Article  PubMed  CAS  Google Scholar 

  25. Sharma G, Hanania NA, Shim YM. The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6(7):573–80.

    Article  PubMed  CAS  Google Scholar 

  26. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple co-morbid diseases. J Am Med Assoc. 2005;294(6):716–24.

    Article  CAS  Google Scholar 

  27. Wilper AP, Woolhandler S, Lasser KE, et al. A national study of chronic disease prevalence and access to care in uninsured U.S. adults. Ann Intern Med. 2008;149(3):170–6.

    Article  PubMed  Google Scholar 

  28. Boulet LP, Turcotte H, Turcot O, et al. Airway inflammation in asthma with incomplete reversibility of airflow obstruction. Respir Med. 2003;97:739–44.

    Article  PubMed  CAS  Google Scholar 

  29. Mannino DM, Hole D, Gillis C, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(3):627–43.

    Article  PubMed  CAS  Google Scholar 

  30. Fabbri L, Ferrari R. Chronic disease in the elderly: back to the future of internal medicine. Breathe. 2006;3:41–9.

    Google Scholar 

  31. Luppi F, Franco F, Beghé B, et al. Treatment of chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc. 2008;5:848–56.

    Article  PubMed  Google Scholar 

  32. Agustí A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc. 2007;4(7):522–5.

    Article  PubMed  Google Scholar 

  33. Quinet P, Young CA, Héritier F. The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease. Ann Phys Rehabil Med. 2010;53(2):69–76.

    Article  PubMed  CAS  Google Scholar 

  34. Janssens W, Vandenbrande P, Hardeman E, et al. Inspiratory flow rates at different levels of resistance in elderly COPD patients. Eur Respir J. 2008;31(1):78–83.

    Article  PubMed  CAS  Google Scholar 

  35. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–22.

    Article  PubMed  CAS  Google Scholar 

  36. Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177(1):19–26.

    Article  PubMed  CAS  Google Scholar 

  37. Banning M. Older people and adherence with medication: a review of the literature. Int J Nurs Stud. 2008;45(10):1550–61.

    Article  PubMed  Google Scholar 

  38. Goeman DP, Douglass JA. Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions. Drugs Aging. 2007;24(5):381–94.

    Article  PubMed  Google Scholar 

  39. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105(3):477–84.

    Article  PubMed  Google Scholar 

  40. Gibson PG, Talbot PI, Toneguzzi RC. Self-management, autonomy, and quality of life in asthma. Chest. 1995;107(4):1003–8.

    Article  PubMed  CAS  Google Scholar 

  41. Little P, Everitt H, Williamson I. Preferences of patients for patient centered approach to consultation in primary care: observational study. BMJ. 2001;322(7284):468–72.

    Article  PubMed  CAS  Google Scholar 

  42. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35(4):913–22.

    Article  PubMed  CAS  Google Scholar 

  43. GINA. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda (MD): Global Initiative for Asthma (GINA), National Heart, Lung and Blood Institute (NHLBI); 2006.

  44. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of COPD 2006 Update. Am J Respir Crit Care Med. 2007;176:532–55.

    Article  PubMed  Google Scholar 

  45. Gibson PG, Simpson JS. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728–35.

    Article  PubMed  CAS  Google Scholar 

  46. Snider GL. Distinguishing among asthma, chronic bronchitis, and emphysema. Chest. 1985;87(1 Suppl):35S–9S.

    PubMed  CAS  Google Scholar 

  47. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:s77–121.

    Google Scholar 

  48. Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124:474–81.

    Article  PubMed  Google Scholar 

  49. Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax. 2008;63:761–7.

    Article  PubMed  CAS  Google Scholar 

  50. Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J. 2009;34(4):812–8.

    Article  PubMed  CAS  Google Scholar 

  51. Vonk JM, Jongepier H, Panhuysen CIM, et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58:322–7.

    Article  PubMed  CAS  Google Scholar 

  52. Calverley PM, Burge PS, Spencer S, et al. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax. 2003;58(8):659–64.

    Article  PubMed  CAS  Google Scholar 

  53. Reid DW, Soltani A, Johns DP, et al. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease. Intern Med J. 2003;33(12):572–7.

    Article  PubMed  CAS  Google Scholar 

  54. Simpson JL, Scott R, Boyle M, et al. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006;11:54–61.

    Article  PubMed  Google Scholar 

  55. Gorska K, Krenke R, Korczynski P, et al. Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma. J Physiol Pharmacol. 2008;59(Suppl 6):261–70.

    PubMed  Google Scholar 

  56. Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J. 2007;29(5):906–13.

    Article  PubMed  CAS  Google Scholar 

  57. Simpson JL, Powell H, Boyle MJ, et al. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008;177(2):148–55.

    Article  PubMed  CAS  Google Scholar 

  58. Hargreave FE, Nair P. The definition and diagnosis of asthma. Clin Exp Allergy. 2009;39:1652–8.

    Article  PubMed  CAS  Google Scholar 

  59. D’silva L, Cook RJ, Allen CJ, et al. Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med. 2007;101:2217–20.

    Article  PubMed  Google Scholar 

  60. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Bethesda (MD): Global Initiative for Chronic Obstructive Lung Disease; 2011.

  61. McKenzie DK, Abramson M, Crockett AJ, et al. The COPD-X Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2009. Brisbane: Australian Lung Foundation; 2009. http://www.copdx.org.au/guidelines/index.asp. Accessed 3 Feb 2009.

  62. Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000;320(7245):1297–303.

    Article  PubMed  CAS  Google Scholar 

  63. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005;60(12):992–7.

    Article  PubMed  CAS  Google Scholar 

  64. Gibson PG, Powell H, Coughlin J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database of Systematic Reviews. 2003;(3):CD001117.

  65. Effing TW, Monninkhof EM, van der Valk PDLPM, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2007;(4):CD002990.

  66. Willemse BW, Postma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464–76.

    Article  PubMed  CAS  Google Scholar 

  67. Franceschi C, Bonafè M. Centenarians as a model for healthy aging. Biochem Soc Trans. 2003;31(2):457–61.

    Article  PubMed  CAS  Google Scholar 

  68. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;1(370):797–9.

    Article  Google Scholar 

  69. Agustí AG, Noguera A, Sauleda J, et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:347–60.

    Article  PubMed  Google Scholar 

  70. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–80.

    Article  PubMed  CAS  Google Scholar 

  71. Yokoyama A, Kohno N, Fujino S, et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med. 1995;151(5):1354–8.

    Article  PubMed  CAS  Google Scholar 

  72. Takemura M, Matsumoto H, Niimi A, et al. High sensitivity C-reactive protein in asthma. Eur Respir J. 2006;27(5):908–12.

    PubMed  CAS  Google Scholar 

  73. Higashimoto Y, Yamagata Y, Taya S, et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology. 2008;13:128–33.

    PubMed  Google Scholar 

  74. Pauwels R, Calverley P, Buist AS, et al. COPD exacerbations: the importance of a standard definition. Resp Med. 2004;98:99–107.

    Article  CAS  Google Scholar 

  75. Hurst JR, Wedzicha JA. The biology of a chronic obstructive pulmonary disease exacerbation. Clin Chest Med. 2007;28(3):525–36.

    Article  PubMed  Google Scholar 

  76. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–85.

    Article  PubMed  CAS  Google Scholar 

  77. Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J. 2011;37(3):516–22.

    Article  PubMed  CAS  Google Scholar 

  78. Lopez-Campos J, Arellano E, Calero C, et al. Determination of inflammatory biomarkers in patients with COPD: a comparison of different assays. BMC Med Res Methodol. 2012;12(1):40.

    Article  PubMed  CAS  Google Scholar 

  79. Bozinovski S, Uddin M, Vlahos R, et al. Serum amyloid A opposes lipoxin A to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA. 2012;109(3):935–40.

    Article  PubMed  CAS  Google Scholar 

  80. Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;23:23.

    Google Scholar 

  81. Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008;63(12):1058–63.

    Google Scholar 

  82. Verrills NM, Irwin JA, He XY, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(12):1633–43.

    Article  PubMed  CAS  Google Scholar 

  83. American Healthways, Johns Hopkins. Standard outcome metrics and evaluation outcome methodology for disease management programmes. Second Annual Disease Management Outcomes Summit; 2002 Nov 7–10; Palm Desert, CA. Franklin, TN: American Healthways; 2002.

  84. Vitry AI, Zhang Y. Quality of Australian clinical guidelines and relevance to the care of older people with multiple comorbid conditions. Med J Aust. 2008;189(7):360–5.

    PubMed  Google Scholar 

  85. Craig BM, Kraus CK, Chewning BA, et al. Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status. BMC Health Serv Res. 2008;8:1–9.

    Google Scholar 

  86. Costantino G, Rusconi AM, Duca PG, et al. Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice. Intern Emerg Med. 2008;4(2):117–22.

    Article  PubMed  Google Scholar 

  87. Travers J, Marsh S, Williams M, et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax. 2007;62(3):219–23.

    Article  PubMed  Google Scholar 

  88. Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med. 2007;101(6):1313–20.

    Article  PubMed  Google Scholar 

  89. Ware JH, Hamel MB. Pragmatic trials—guides to better patient care? N Engl J Med. 2011;364(18):1685–7.

    Article  PubMed  CAS  Google Scholar 

  90. Decramer M, Celli B, Kesten S, et al. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009;374(9696):1171–8.

    Article  PubMed  CAS  Google Scholar 

  91. Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy. 2009;39(4):478–90.

    Article  PubMed  CAS  Google Scholar 

  92. Powell H, Murphy VE, Taylor DR, et al. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet. 2011;378(9795):983–90.

    Article  PubMed  CAS  Google Scholar 

  93. Hunter DJ, Fairfield G. Disease management. Br Med J. 1997;315(7099):50–3.

    Article  CAS  Google Scholar 

  94. Hunter DJ. Disease management: has it a future? It has a compelling logic, but needs to be tested in practice. Br Med J. 2000;320(7234):530.

    Article  CAS  Google Scholar 

  95. Solomon D, Brown SA, Brummel-Smith K, et al. Best paper of the 1980 s: National Institutes of Health Consensus Development Conference Statement: geriatric assessment methods for clinical decision-making. 1988. J Am Geriatr Soc. 2003;51(10):1490–4.

    Article  PubMed  Google Scholar 

  96. Vliek S, Melis RJ, Faes M, et al. Single versus multicomponent intervention in frail elderly: simplicity or complexity as precondition for success? J Nutr Health Aging. 2008;12(5):319–22.

    Article  PubMed  CAS  Google Scholar 

  97. Stuck AE, Siu AL, Wieland GD, et al. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993;342:1032–6.

    Article  PubMed  CAS  Google Scholar 

  98. McDonald VM, Higgins I, Wood LG, et al. Multidimensional assessment and individualised management of obstructive airway diseases (OAD) in older adults. Respirology. 2011;16:13.

    Article  Google Scholar 

  99. Koff PB, Jones RH, Cashman JM, et al. Proactive integrated care improves quality of life in patients with COPD. Eur Respir J. 2009;33(5):1031–8.

    Article  PubMed  CAS  Google Scholar 

  100. Rice KL, Dewan N, Bloomfield HE, et al. Disease management program for chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182(7):890–6.

    Article  PubMed  Google Scholar 

  101. Reilly JJ. COPD and declining FEV1—time to divide and conquer? N Engl J Med. 2008;359:1616–8.

    Article  PubMed  CAS  Google Scholar 

  102. McDonald VM, Higgins I, Simpson JL, et al. The importance of clinical management problems in older people with COPD and asthma: do patients and physicians agree? Prim Care Respir J. 2011;20(4):389–95.

    Article  PubMed  Google Scholar 

  103. National Ageing Research Institute. What is person-centred health care? A literature review. Melbourne: Ageing and Complex Care, Continuing Care, Integrated Care, Wellbeing, Integrated Care and Ageing, Department of Health; 2006.

  104. Bauman AE, Fardy HJ, Harris PG. Getting it right: why bother with patient-centered care? Med J Aust. 2003;179(5):253–6.

    PubMed  Google Scholar 

  105. Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77.

    Article  PubMed  Google Scholar 

  106. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360(10):985–93.

    Article  PubMed  CAS  Google Scholar 

  107. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002;30:1715–21.

    Article  Google Scholar 

  108. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J. 2006;27:483–94.

    Article  PubMed  CAS  Google Scholar 

  109. Petsky HL, Kynaston JA, Turner C, et al. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Cochrane Database of Systematic Reviews. 2007; (2): CD005603.

  110. Albert RK, Connett J, Bailey WC, et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med. 2011;365(8):689–98.

    Article  PubMed  CAS  Google Scholar 

  111. Seemungal TA, Wilkinson TM, Hurst JR, et al. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med. 2008;178(11):1139–47.

    Article  PubMed  CAS  Google Scholar 

  112. He ZY, Ou LM, Zhang JQ, et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. Respiration. 2010;80(6):445–52.

    Article  PubMed  CAS  Google Scholar 

  113. Figueiredo Bde C, Ibiapina Cda C. The role of macrolides in noncystic fibrosis bronchiectasis. Pulm Med. 2011; 2011: 751982. doi:10.1155/2011/751982.

  114. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003;290(13):1749–56.

    Article  PubMed  CAS  Google Scholar 

  115. Tateda K, Standiford TJ, Pechere JC, et al. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Curr Pharm Des. 2004;10:3055–65.

    Article  PubMed  CAS  Google Scholar 

  116. López-Boado YS, Rubin BK. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases. Curr Opin Pharmacol. 2008;8:286–91.

    Article  PubMed  CAS  Google Scholar 

  117. Mora S, Ridker PM. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)—can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol. 2006;97(2A):33A–41A.

    Article  PubMed  CAS  Google Scholar 

  118. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352(1):20–8.

    Article  PubMed  CAS  Google Scholar 

  119. Lee T-M, Lin M-S, Chang N-C. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Am J Cardiol. 2008;101(4):530–5.

    Article  PubMed  CAS  Google Scholar 

  120. Suissa S. Co-morbidity in COPD: the effects of cardiovascular drug therapies. Respiration. 2010;80(1):3–7.

    Article  PubMed  CAS  Google Scholar 

  121. Lee T-M, Chen C–C, Shen H-N, et al. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Clin Sci. 2009;116(6):497–505.

    Article  PubMed  CAS  Google Scholar 

  122. Blamoun AI, Batty GN, DeBari VA, et al. Statins may reduce episodes of exacerbation and the requirement for intubation in patients with COPD: evidence from a retrospective cohort study. Int J Clin Pract. 2008;62(9):1373–8.

    Article  PubMed  CAS  Google Scholar 

  123. Keddissi JI, Younis WG, Chbeir EA, et al. The use of statins and lung function in current and former smokers. Chest. 2007;132(6):1764–71.

    Article  PubMed  CAS  Google Scholar 

  124. Mancini GB, Etminan M, Zhang B, et al. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol. 2006;47(12):2554–60.

    Article  PubMed  CAS  Google Scholar 

  125. Frost FJ, Petersen H, Tollestrup K, et al. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest. 2007;131(4):1006–12.

    Article  PubMed  CAS  Google Scholar 

  126. Ishida W, Kajiwara T, Taneichi H, et al. Decrease in mortality rate of chronic obstructive pulmonary disease (COPD) with statin use: a population-based analysis in Japan. Tohoku J Exp Med. 2007;212(3):265–73.

    Article  PubMed  Google Scholar 

  127. van Gestel YRBM, Hoeks SE, Sin DD, et al. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease. Am J Cardiol. 2008;102(2):192–6.

    Article  PubMed  CAS  Google Scholar 

  128. Ulrik CS, von Linstow ML, Nepper-Christensen S, Porsbjerg C, Backer V. Chronic mucus hypersecretion: a marker of asthma in young adults. Respir Med. 2005;99:1576–82.

    Google Scholar 

  129. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163:1256–76.

    Article  PubMed  CAS  Google Scholar 

  130. Rogers DF. Mucoactive agents for airway mucus hypersecretory diseases. Respir Care. 2007;52:1176–93.

    PubMed  Google Scholar 

  131. Henke MO, Shah SA, Rubin BK. The role of airway secretions in COPD—clinical applications. COPD. 2005;2:377–90.

    Article  PubMed  Google Scholar 

  132. Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354:229–40.

    Article  PubMed  CAS  Google Scholar 

  133. Wark P, McDonald VM. Nebulised hypertonic saline for cystic fibrosis. Cochrane Database of Systematic Reviews. 2009;(2): CD001506.

  134. Pavia D, Thomson ML, Clarke SW. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am J Respir Crit Care Med. 1978;117:199–203.

    CAS  Google Scholar 

  135. Clarke SW, Lopez-Vidriero MT, Pavia D, et al. The effect of sodium 2-mercapto-ethane sulphonate and hypertonic saline aerosols on bronchial clearance in chronic bronchitis. Br J Clin Pharmacol. 1979;7:39–44.

    Article  PubMed  CAS  Google Scholar 

  136. Daviskas E, Anderson SD, Young IH. Inhaled mannitol changes the sputum properties in asthmatics with mucus hypersecretion. Respirology. 2007;12(5):683–91.

    Article  PubMed  Google Scholar 

  137. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database of Systematic Reviews. 2006;(2): CD002996.

  138. Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259–65.

    Article  PubMed  Google Scholar 

  139. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952–9.

    Article  PubMed  Google Scholar 

  140. Shamsham F, Mitchell J. Essentials of the diagnosis of heart failure. Fam Physician. 2000;61:1319–28.

    CAS  Google Scholar 

  141. Roth SM, Metter EJ, Ling S, et al. Inflammatory factors in age-related muscle wasting. Curr Opin Rheumatol. 2006;18:625–30.

    Article  PubMed  CAS  Google Scholar 

  142. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147:1151–6.

    Article  PubMed  CAS  Google Scholar 

  143. Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(4):859–67.

    Article  PubMed  CAS  Google Scholar 

  144. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288(14):1723–7.

    Article  PubMed  Google Scholar 

  145. Oreopoulos A, Kalantar-Zadeh K, Sharma AM, et al. The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med. 2009;24(4):643–59.

    Article  Google Scholar 

  146. Losonczy KG, Harris TB, Cornoni-Huntley J, et al. Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? Am J Epidemiol. 1995;141(4):312–21.

    Article  PubMed  CAS  Google Scholar 

  147. Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging. J Am Geriatr Soc. 2001;49(7):968–79.

    Article  PubMed  CAS  Google Scholar 

  148. Villareal DT, Apovian CM, Kushner RF, et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr. 2005;82(5):923–34.

    PubMed  CAS  Google Scholar 

  149. Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003;123(5):1460–6.

    Article  PubMed  Google Scholar 

  150. Landbo C, Prescott E, Lange PT, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:1856–61.

    Article  PubMed  CAS  Google Scholar 

  151. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–12.

    Article  PubMed  CAS  Google Scholar 

  152. Schols AM, Slangen J, Volovics L, et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1791–7.

    Article  PubMed  CAS  Google Scholar 

  153. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–209.

    Article  PubMed  Google Scholar 

  154. Flicker L, McCaul KA, Hankey GJ, et al. Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc. 2010;58(2):234–41.

    Article  PubMed  Google Scholar 

  155. Franssen FME, O’Donnell DE, Goossens GH, et al. Obesity and the lung: 5. Obesity and COPD. Thorax. 2008;63:1110–7.

    Article  PubMed  CAS  Google Scholar 

  156. Steuten LM, Creutzberg EC, Vrijhoef HJ, et al. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J. 2006;15:84–91.

    Article  PubMed  Google Scholar 

  157. Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res. 2007;8:7.

    Article  PubMed  Google Scholar 

  158. Aronson D, Bartha P, Zinder O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord. 2004;28:674–9.

    Article  PubMed  CAS  Google Scholar 

  159. Florez H, Castillo-Florez S, Mendez A, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract. 2006;71:92–100.

    Article  PubMed  CAS  Google Scholar 

  160. Vandenbergh E, Van de Woestijne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Am Rev Respir Dis. 1967;95:556–66.

    PubMed  CAS  Google Scholar 

  161. Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178:322–3.

    Article  Google Scholar 

  162. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27(3):495–503.

    Article  PubMed  CAS  Google Scholar 

  163. Wood LG, Gibson PG. Dietary factors lead to innate immune activation in asthma. Pharmacol Ther. 2009;123(1):37–53.

    Article  PubMed  CAS  Google Scholar 

  164. Harrington JJ, Lee-Chiong T Jr. Sleep and older patients. Clin Chest Med. 2007;28(4):673–84.

    Article  PubMed  Google Scholar 

  165. Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18(6):425–32.

    PubMed  CAS  Google Scholar 

  166. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33(4):897–906.

    Article  PubMed  Google Scholar 

  167. Zamarrón C, García Paz V, Morete E, et al. Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J Chron Obstruct Pulmon Dis. 2008;3(4):671–82.

  168. Jorgensen NR, Schwarz P, Holme I, et al. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—a cross sectional study. Respir Med. 2007;101:177–85.

    Article  PubMed  CAS  Google Scholar 

  169. Israel E, Banerjee TR, Fitzmaurice GM, et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345(13):941–7.

    Article  PubMed  CAS  Google Scholar 

  170. Ip M, Lam K, Yam L, et al. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105(6):1722–7.

    Article  PubMed  CAS  Google Scholar 

  171. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–9.

    Article  PubMed  CAS  Google Scholar 

  172. Kvaal K, Macijauskiene J, Engedal K, et al. High prevalence of anxiety symptoms in hospitalized geriatric patients. Int J Geriatr Psychiatry. 2001;16(7):690–3.

    Article  PubMed  CAS  Google Scholar 

  173. Cafarella PA, Effing TW, Usmani ZA, et al. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology. 2012;17(4):627–38.

    Article  PubMed  Google Scholar 

  174. Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2003;18(5):412–6.

    Article  PubMed  Google Scholar 

  175. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–71.

    Article  PubMed  CAS  Google Scholar 

  176. Kunik ME, Roundy K, Veazey C, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.

    Article  PubMed  Google Scholar 

  177. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160(14):2101–7.

    Article  PubMed  CAS  Google Scholar 

  178. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing. 2005;34(5):491–6.

    Article  PubMed  Google Scholar 

  179. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56S.

    Article  PubMed  Google Scholar 

  180. Rennard SI, Farmer SG. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2004;1(2):88–92.

    Article  PubMed  Google Scholar 

  181. Hurst JR, Donaldson GC, Quint JK, et al. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):369–74.

    Article  PubMed  Google Scholar 

  182. Bai TR, Vonk JM, Postma DS, et al. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452–6.

    Article  PubMed  CAS  Google Scholar 

  183. Clarke SW. Management of mucus hypersecretion. Eur Resp J. 1987;136–44:153.

    Google Scholar 

  184. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med. 1996;153:1530–5.

    Article  PubMed  CAS  Google Scholar 

  185. Rogers DF. Airway mucus hypersecretion in asthma: an undervalued pathology? Curr Opin Pharmacol. 2004;4(3):241–50.

    Article  PubMed  CAS  Google Scholar 

  186. Roche N. Activity limitation: a major consequence of dyspnoea in COPD. Eur Respir Rev. 2009;18(112):54–7.

    Article  PubMed  CAS  Google Scholar 

  187. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–7.

    Article  PubMed  Google Scholar 

  188. Schönhofer B, Ardes P, Geibel M, et al. Evaluation of a movement detector to measure daily activity in patients with chronic lung disease. Eur Respir J. 1997;10(12):2814–9.

    Article  PubMed  Google Scholar 

  189. Jones PW. Activity limitation and quality of life in COPD. COPD. 2007;4(3):273–8.

    Article  PubMed  Google Scholar 

  190. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med. 2007;175(5):458–63.

    Article  PubMed  Google Scholar 

  191. Strine TW, Balluz LS, Ford ES. The associations between smoking, physical inactivity, obesity, and asthma severity in the general US population. J Asthma. 2008;44(8):651–8.

    Article  Google Scholar 

  192. Sherriff A, Maitra A, Ness AR, et al. Association of duration of television viewing in early childhood with the subsequent development of asthma. Thorax. 2009;64(4):321–5.

    Article  PubMed  CAS  Google Scholar 

  193. Rasmussen F, Lambrechtsen J, Siersted HC, et al. Low physical fitness in childhood is associated with the development of asthma in young adulthood: the Odense Schoolchild Study. Eur Respir J. 2000;16(5):866–70.

    Article  PubMed  CAS  Google Scholar 

  194. Virchow JC, Crompton GK. Dal Negro R, et al. Importance of inhaler devices in the management of airway disease. Respir Med. 2008;102:10–9.

    Article  PubMed  CAS  Google Scholar 

  195. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75(1):18–25.

    Article  PubMed  Google Scholar 

  196. Allen SC, Warwick-Sanders M, Baxter M. A comparison of four tests of cognition as predictors of inability to learn to use a metered dose inhaler in old age. Int J Clin Pract. 2009;63(8):1150–3.

    Article  PubMed  CAS  Google Scholar 

  197. Board M, Allen SC. A simple drawing test to identify patients who are unlikely to be able to learn to use an inhaler. Int J Clin Pract. 2006;60(5):510–3.

    Article  PubMed  CAS  Google Scholar 

  198. Quinet P, Young CA, Héritier F. The use of dry powder inhaler devices by elderly patients suffering from chronic obstructive pulmonary disease. Ann Phys Rehabil Med. 2010;53(2):69–76.

    Article  PubMed  CAS  Google Scholar 

  199. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22(3):231–55.

    Article  PubMed  Google Scholar 

  200. Rand CS. Patient adherence with COPD therapy. Eur Respir Rev. 2005;14(96):97–101.

    Article  Google Scholar 

  201. Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma. 2010;47(2):162–5.

    Article  PubMed  Google Scholar 

  202. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–9.

    Article  PubMed  Google Scholar 

  203. Horne R. Compliance, adherence, and concordance—implications for asthma treatment. Chest. 2006;130(1 Suppl):65S–72S.

    Article  PubMed  Google Scholar 

  204. Jenkins L, Britten N, Stevenson F, et al. Developing and using quantitative instruments for measuring doctor-patient communication about drugs. Patient Educ Couns. 2003;50(3):273–8.

    Article  PubMed  Google Scholar 

  205. Irwin RS, Richardson ND. Patient-Focused Care; using the right tools. Chest. 2006;130:73S–82S.

    Article  PubMed  Google Scholar 

  206. Marin L, Colombo P, Bebawy M, et al. Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Expert Opin Drug Deliv. 2011;8(9):1205–20.

    Article  PubMed  CAS  Google Scholar 

  207. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews. 2008;(1):CD000146.

  208. Jimenez Ruiz CA, Ramos Pinedo A, Cicero Guerrero A, et al. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications. Nicotine Tob Res. 2012;17:17.

    Google Scholar 

  209. Pesek R, Lockey R. Vaccination of adults with asthma and COPD. Allergy. 2011;66(1):25–31.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Dr. Vanessa McDonald has been reimbursed for participation in symposia funded by AstraZeneca, Boehinger Ingelheim, GlaxoSmithKline and Novartis. She has participated in studies funded by GlaxoSmithKline and Novartis. Professor Isabel Higgins has no conflict of interest to declare. Professor Peter Gibson holds an NHMRC Practitioner Fellowship. He has been reimbursed for participation in symposia funded by AstraZeneca, Boehinger Ingelheim, GlaxoSmithKline and Novartis. He has participated in studies funded by Pharmaxis and GlaxoSmithKline.

Author information

Authors and Affiliations

  1. Priority Research Centre for Asthma and Respiratory Diseases, University of Newcastle, Newcastle, NSW, Australia

    Vanessa M. McDonald & Peter G. Gibson

  2. School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia

    Vanessa M. McDonald & Peter G. Gibson

  3. School of Nursing and Midwifery, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia

    Vanessa M. McDonald & Isabel Higgins

  4. Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton, NSW, Australia

    Vanessa M. McDonald & Peter G. Gibson

  5. Woolcock Institute of Medical Research, Sydney, NSW, Australia

    Peter G. Gibson

  6. Level 2 West Wing, Hunter Medical Research Institute, Locked bag 1000, New Lambton, NSW, 2305, Australia

    Peter G. Gibson

Authors
  1. Vanessa M. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isabel Higgins
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter G. Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter G. Gibson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDonald, V.M., Higgins, I. & Gibson, P.G. Managing Older Patients with Coexistent Asthma and Chronic Obstructive Pulmonary Disease. Drugs Aging 30, 1–17 (2013). https://doi.org/10.1007/s40266-012-0042-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-012-0042-z

Keywords

Search

Navigation